Aziyo biologics to present at the h.c. wainwright bioconnect virtual conference

Silver spring, md., dec. 27, 2021 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that members of management will present at the upcoming h.c. wainwright bioconnect virtual conference.
AZYO Ratings Summary
AZYO Quant Ranking